ReviewEpidemiology and infection2015
The status of tularemia in Europe in a one-health context: a review.
Review in Epidemiology and infection, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
89 citing papers in PubMed.
- Very Low Serological Evidence of Exposure toPathogens (Basel, Switzerland) · 2026Article
- Article
- Spatial Epidemiology and Ecological Determinants of Ticks and Tick-Borne Pathogens Co-Circulation in Brijuni National Park, Croatia.International journal of environmental research and public health · 2026Article
- Surveillance of tick-borne pathogens in ticks collected from Swiss residents.Parasites & vectors · 2026Article
- Tularemia: Historical Perspectives and Current Challenges of a Re-Emerging Zoonosis.Biomedicines · 2026Review
- Francisella spp. as an overlooked cause of acute undifferentiated febrile illness in Colombia? Unexpected evidence from febrile patients negative for other common and neglected etiologies in Villeta municipality.Tropical medicine and health · 2026Article
- First molecular detection ofVeterinary and animal science · 2025Article
- Country-wide assessment of tick-borne pathogens collected in ticks between 2021 and 2024 in Germany, with a focus onOne health (Amsterdam, Netherlands) · 2025Article
- Clinical Characteristics and Treatment Strategies in a Cohort of Patients with Tularemia: A Retrospective Multicenter Analysis of 65 Cases in Germany.Antibiotics (Basel, Switzerland) · 2025Article
- An Outbreak of Pulmonary Tularemia in Slovenia in Summer 2024.Epidemiologia (Basel, Switzerland) · 2025Article
- Head and Neck Manifestations of Tularemia in Tyrol (Austria): A Case Series.Diagnostics (Basel, Switzerland) · 2025Article
- An Emerging Role for Ticks as Vectors of Tularaemia in Sweden.Veterinary medicine and science · 2025Article
- Modeling the differential effect of prescribed fire on multi-vector tick-borne tularemia disease.PloS one · 2025Article
- Prosthetic joint infection as an unusual presentation ofIDCases · 2025Article
- The European Union One Health 2023 Zoonoses report.EFSA journal. European Food Safety Authority · 2024Article
- Article
- Investigation of Viral, Bacterial and Parasitic Zoonotic Diseases in Rodents in Turkey.Veterinary medicine and science · 2024Article
- Clinical features of tularemia in cats: a retrospective study from 2000 to 2021.Journal of feline medicine and surgery · 2024Article
- Tick-Borne Bacterial Diseases in Europe: Threats to public health.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024Review
- Francisella tularensis Infection Causing Parinaud Oculoglandular Syndrome.The American journal of case reports · 2024Article
29 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The bacterium Francisella tularensis causes the vector-borne zoonotic disease tularemia, and may infect a wide range of hosts including invertebrates, mammals and birds. Transmission to humans occurs through contact with infected animals or contaminated environments, or through arthropod vectors. Tularemia has a broad geographical distribution, and there is evidence which suggests local emergence or re-emergence of this disease in Europe. This review was developed to provide an update on the geographical distribution of F. tularensis in humans, wildlife, domestic animals and vector species, to identify potential public health hazards, and to characterize the epidemiology of tularemia in Europe. Information was collated on cases in humans, domestic animals and wildlife, and on reports of detection of the bacterium in arthropod vectors, from 38 European countries for the period 1992-2012. Multiple international databases on human and animal health were consulted, as well as published reports in the literature. Tularemia is a disease of complex epidemiology that is challenging to understand and therefore to control. Many aspects of this disease remain poorly understood. Better understanding is needed of the epidemiological role of animal hosts, potential vectors, mechanisms of maintenance in the different ecosystems, and routes of transmission of the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.